Cargando…

The utility of biomarker risk prediction score in patients with chronic heart failure

BACKGROUND: Chronic heart failure (CHF) has been remained a leading cause of cardiovascular morbidity and mortaluty. The risk stratification of CHF individuals based on clinical criteria and biomarkers' models may improve medical care and probably increase efficacy of treatment strategy. Howeve...

Descripción completa

Detalles Bibliográficos
Autores principales:	Berezin, Alexander E., Kremzer, Alexander A., Martovitskaya, Yulia V., Berezina, Tatyana A., Samura, Tatyana A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4787185/ https://www.ncbi.nlm.nih.gov/pubmed/26973794 http://dx.doi.org/10.1186/s40885-016-0041-1

Ejemplares similares

The predictive role of circulating microparticles in patients with chronic heart failure()
por: Berezin, Alexander E., et al.
Publicado: (2014)

Serum Uric Acid Predicts Declining of Circulating Proangiogenic Mononuclear Progenitor Cells in Chronic Heart Failure Patients
por: Berezin, Alexander E., et al.
Publicado: (2014)

The Association of Subclinical Hypothyroidism and Pattern of Circulating Endothelial-Derived Microparticles Among Chronic Heart Failure Patients
por: Berezin, Alexander E., et al.
Publicado: (2015)

Pattern of circulating microparticles in chronic heart failure patients with metabolic syndrome: Relevance to neurohumoral and inflammatory activation
por: Berezin, Alexander E., et al.
Publicado: (2015)

The signature of circulating microparticles in heart failure patients with metabolic syndrome
por: Berezin, Alexander E, et al.
Publicado: (2016)

Pattern of endothelial progenitor cells and apoptotic endothelial cell-derived microparticles in chronic heart failure patients with preserved and reduced left ventricular ejection fraction
por: Berezin, Alexander E., et al.
Publicado: (2016)

Circulating Endothelial-Derived Apoptotic Microparticles in the Patients with Ischemic Symptomatic Chronic Heart Failure: Relevance of Pro-Inflammatory Activation and Outcomes
por: Berezin, Alexander E., et al.
Publicado: (2014)

Data regarding association between serum osteoprotegerin level, numerous of circulating endothelial-derived and mononuclear-derived progenitor cells in patients with metabolic syndrome
por: Berezin, Alexander E., et al.
Publicado: (2016)

Circulating thrombospondin-2 in patients with moderate-to-severe chronic heart failure due to coronary artery disease
por: Berezin, Alexander E., et al.
Publicado: (2016)

Predictive value of circulating osteonectin in patients with ischemic symptomatic chronic heart failure
por: Berezin, Alexander E., et al.
Publicado: (2015)

Adropin Predicts Chronic Kidney Disease in Type 2 Diabetes Mellitus Patients with Chronic Heart Failure
por: Berezina, Tetiana A., et al.
Publicado: (2023)

Low Plasma Levels of Irisin Predict Acutely Decompensated Heart Failure in Type 2 Diabetes Mellitus Patients with Chronic Heart Failure
por: Berezin, Alexander A., et al.
Publicado: (2023)

Editorial: Prognostication of Heart Failure Evolution: From Circulating Biomarkers to Genetic Risk Predictive Score
por: Berezin, Alexander E., et al.
Publicado: (2021)

Biomarkers in Heart Failure: From Research to Clinical Practice
por: Berezin, Alexander E., et al.
Publicado: (2023)

The Impact of SGLT2 Inhibitor Dapagliflozin on Adropin Serum Levels in Men and Women with Type 2 Diabetes Mellitus and Chronic Heart Failure
por: Berezin, Alexander A., et al.
Publicado: (2023)

Predictive value of serum irisin for chronic heart failure in patients with type 2 diabetes mellitus
por: Berezin, Alexander A., et al.
Publicado: (2022)

Analysis of Various Subsets of Circulating Mononuclear Cells in Asymptomatic Coronary Artery Disease
por: Berezin, Alexander E., et al.
Publicado: (2013)

Prognostication in Different Heart Failure Phenotypes: The Role of Circulating Biomarkers
por: Berezin, Alexander E.
Publicado: (2016)

Discriminative Utility of Apelin-to-NT-Pro-Brain Natriuretic Peptide Ratio for Heart Failure with Preserved Ejection Fraction among Type 2 Diabetes Mellitus Patients
por: Berezin, Alexander A., et al.
Publicado: (2022)

Epigenetics in heart failure phenotypes()
por: Berezin, Alexander
Publicado: (2016)

Extracellular Endothelial Cell-Derived Vesicles: Emerging Role in Cardiac and Vascular Remodeling in Heart Failure
por: Berezin, Alexander E., et al.
Publicado: (2020)

Serum Levels of Irisin Predict Cumulative Clinical Outcomes in Heart Failure Patients With Type 2 Diabetes Mellitus
por: Berezin, Alexander A., et al.
Publicado: (2022)

Discriminative Value of Serum Irisin in Prediction of Heart Failure with Different Phenotypes among Patients with Type 2 Diabetes Mellitus
por: Berezin, Alexander A., et al.
Publicado: (2022)

Myokines and Heart Failure: Challenging Role in Adverse Cardiac Remodeling, Myopathy, and Clinical Outcomes
por: Berezin, Alexander E., et al.
Publicado: (2021)

Serum Uric Acid as a Marker of Coronary Calcification in Patients with Asymptomatic Coronary Artery Disease with Preserved Left Ventricular Pump Function
por: Berezin, A. E., et al.
Publicado: (2013)

Emerging Role of Adipocyte Dysfunction in Inducing Heart Failure Among Obese Patients With Prediabetes and Known Diabetes Mellitus
por: Berezin, Alexander E., et al.
Publicado: (2020)

The Effect of SGLT2 Inhibitor Dapagliflozin on Serum Levels of Apelin in T2DM Patients with Heart Failure
por: Berezin, Alexander A., et al.
Publicado: (2022)

Cardiac Hepatopathy: New Perspectives on Old Problems through a Prism of Endogenous Metabolic Regulations by Hepatokines
por: Berezin, Alexander A., et al.
Publicado: (2023)

Circulating Cardiac Biomarkers in Diabetes Mellitus: A New Dawn for Risk Stratification—A Narrative Review
por: Berezin, Alexander E., et al.
Publicado: (2020)

The Association of Glucose Control with Circulating Levels of Red Blood Cell-Derived Vesicles in Type 2 Diabetes Mellitus Patients with Atrial Fibrillation
por: Berezin, Alexander A., et al.
Publicado: (2022)

Interplay between Myokine Profile and Glycemic Control in Type 2 Diabetes Mellitus Patients with Heart Failure
por: Berezin, Alexander A., et al.
Publicado: (2022)

Editorial: Acute heart failure: From bench to bedside
por: Berezin, Alexander E., et al.
Publicado: (2023)

Editorial: Epigenetics in Heart Failure Developing: The Orchestra of Etiology and Comorbidities
por: Berezin, Alexander E., et al.
Publicado: (2022)

A Biomarker-Based Score for Risk of Hospitalization for Heart Failure in Patients With Diabetes
por: Berg, David D., et al.
Publicado: (2021)

Utility of PREDICT-HF score in high-risk Asian heart failure patients receiving sacubitril/valsartan
por: Hsu, Chien-Yi, et al.
Publicado: (2022)

Genetic risk scores to predict the prognosis of chronic heart failure patients in Chinese Han
por: Li, Shiyang, et al.
Publicado: (2019)

Adverse Cardiac Remodelling after Acute Myocardial Infarction: Old and New Biomarkers
por: Berezin, Alexander E., et al.
Publicado: (2020)

Scoring System Based on Electrocardiogram Features to Predict the Type of Heart Failure in Patients With Chronic Heart Failure
por: Hendry, Purnasidha Bagaswoto, et al.
Publicado: (2016)

The Prognostic Role of Polysomnography Parameters in Heart Failure Patients with Previous Decompensation
por: Medvedeva, Elena, et al.
Publicado: (2022)

The Diagnostic and Therapeutic Value of Multimarker Analysis in Heart Failure. An Approach to Biomarker-Targeted Therapy
por: Topf, Albert, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_i686pka99gol1u13hudnh2vf7b